Royalty Pharma PLC (RPRX)
27.62
+0.16
(+0.56%)
USD |
NASDAQ |
Apr 17, 16:00
27.61
0.00 (0.00%)
After-Hours: 20:00
Royalty Pharma Free Cash Flow (Quarterly): 772.63M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 772.63M |
September 30, 2023 | 573.52M |
June 30, 2023 | 607.82M |
March 31, 2023 | 1.034B |
December 31, 2022 | 569.93M |
September 30, 2022 | 538.83M |
June 30, 2022 | 574.95M |
March 31, 2022 | 460.27M |
December 31, 2021 | 489.96M |
September 30, 2021 | 469.76M |
Date | Value |
---|---|
June 30, 2021 | 531.72M |
March 31, 2021 | 526.10M |
December 31, 2020 | 565.67M |
September 30, 2020 | 508.85M |
June 30, 2020 | 489.00M |
March 31, 2020 | 471.10M |
December 31, 2019 | 1.667B |
September 30, 2019 | -769.78M |
June 30, 2019 | 336.79M |
March 31, 2019 | 432.98M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-769.78M
Minimum
Sep 2019
1.667B
Maximum
Dec 2019
548.33M
Average
531.72M
Median
Jun 2021
Free Cash Flow (Quarterly) Benchmarks
Viatris Inc | 278.50M |
Walgreens Boots Alliance Inc | -989.00M |
Pacira BioSciences Inc | 45.79M |
Amphastar Pharmaceuticals Inc | 14.42M |
Maravai LifeSciences Holdings Inc | -9.009M |